SCHEMBL2320195

SCHEMBL2320195

COc1ccc(-c2cc3c(ncc4c(C)nc(C)n43)n2COCC[Si](C)(C)C)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 2/20 0.37
TDP1 Q9NUW8 2/20 0.37
DGAT1 O75907 2/20 0.35
MAPT P10636 6/20 0.35
ALDH1A1 P00352 6/20 0.35
KDM4E B2RXH2 5/20 0.35
LMNA P02545 3/20 0.35
HSD17B10 Q99714 3/20 0.35
USP2 O75604 1/20 0.35
GRIK1 P39086 1/20 0.35
GRIK2 Q13002 1/20 0.35
TP53 P04637 2/20 0.35
BRD4 O60885 1/20 0.34
NTRK1 P04629 2/20 0.34
PIM1 P11309 2/20 0.34
HPGD P15428 2/20 0.34
L3MBTL1 Q9Y468 2/20 0.34
MAPK1 P28482 1/20 0.34
CHEK1 O14757 1/20 0.34
EGFR P00533 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2315378 0.86 TDP1 (0.36) ALOX15TDP1DGAT1MAPTALDH1A1
SCHEMBL2317262 0.84 BRD4 (0.36) ALOX15TDP1DGAT1MAPTALDH1A1
SCHEMBL2318529 0.83 FLT3 (0.36) ALOX15TDP1DGAT1MAPTALDH1A1
SCHEMBL2314920 0.76 DGAT1 (0.38) ALOX15TDP1DGAT1MAPTALDH1A1
SCHEMBL2317159 0.73 TDP1 (0.39) ALOX15TDP1DGAT1MAPTALDH1A1
SCHEMBL1932973 0.72 DGAT1 (0.39) ALOX15TDP1DGAT1MAPTALDH1A1
SCHEMBL1932974 0.72 ALOX15 (0.34) ALOX15TDP1DGAT1MAPTALDH1A1
SCHEMBL2315068 0.71 NPC1 (0.32) DGAT1MAPTNPC1
SCHEMBL2317057 0.71 MAPT (0.35) DGAT1MAPTNPC1
SCHEMBL30862665 0.70 TDP1 (0.38) ALOX15TDP1DGAT1MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140349970-A1 NOVEL TRICYCLIC COMPOUNDS ABBVIE INC. (US) 2014-11-27 US disclosed
US-8785639-B2 Substituted dihydropyrazolo[3,4-D]pyrrolo[2,3-B]pyridines and methods of use thereof ABBVIE INC. (US) 2014-07-22 US disclosed
US-20110190489-A1 Novel Tricyclic Compounds ABBOTT LABORATORIES (US) 2011-08-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140349970-A1 NOVEL TRICYCLIC COMPOUNDS CCNI, IL2, IL4I1 ALOX15 597/4885TDP1 3938/4885DGAT1 2419/4885
US-20110190489-A1 Novel Tricyclic Compounds CCNI, IL2, IL4I1 ALOX15 597/4885TDP1 3938/4885DGAT1 2419/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.